PMID- 24361893 OWN - NLM STAT- MEDLINE DCOM- 20140319 LR - 20220409 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 443 IP - 3 DP - 2014 Jan 17 TI - Pro-inflammatory/Th1 gene expression shift in high glucose stimulated mesangial cells and tubular epithelial cells. PG - 969-74 LID - S0006-291X(13)02141-4 [pii] LID - 10.1016/j.bbrc.2013.12.072 [doi] AB - Diabetic nephropathy (DN) is a major cause of end stage kidney disease and a strong risk factor for cardiovascular diseases. Growing data show chronic inflammation plays an important role for the progression of DN. As for the immune cells, anti-inflammatory leukocytes as well as pro-inflammatory leukocytes play an important role in DN. In addition to leukocytes, renal resident cells contribute to the inflammatory process of DN. However, precise functions, phenotypes and immune balance of renal resident cells remain to be explored. Therefore, we hypothesized that the aberrant immune balance of renal resident cells contributes to the pathogenesis of DN. To explore this possibility, we performed genome-wide transcriptome profiling in mesangial cells and tubular epithelial cells (TECs), which were stimulated by high glucose (HG) and detected the expression of inflammation associated genes. HG increased the mRNA expression of oxidative stress, inflammasome and mammalian target of rapamycin (mTOR) related genes in mesangial cells. Pro-inflammatory/Th1 gene expression was upregulated, but Th2 related gene expression was downregulated in mesangial cells. In TECs, HG stimulation increased pro-inflammatory/Th1/Th2 gene expression. Phosphorylation of signaling proteins shifted towards pro-inflammatory phenotype with suppressed phosphorylation of Th2 related signaling in TECs. The data taken together indicate that HG shifts the immune balance toward pro-inflammatory/Th1 phenotype in mesangial cells and TECs, which might initiate and/or prolong inflammation, thereby resulting in diabetic nephropathy. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Iwata, Yasunori AU - Iwata Y AD - Division of Infection Control, Kanazawa University, Japan; Division of Nephrology, Kanazawa University, Japan. Electronic address: iwata-knz@umin.ac.jp. FAU - Furuichi, Kengo AU - Furuichi K AD - Division of Nephrology, Kanazawa University, Japan; Division of Blood Purification, Kanazawa University, Japan. FAU - Hashimoto, Shinichi AU - Hashimoto S AD - Department of Laboratory Medicine, Kanazawa University, Japan; Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan. FAU - Yokota, Kiyonobu AU - Yokota K AD - Department of Laboratory Medicine, Kanazawa University, Japan. FAU - Yasuda, Haruka AU - Yasuda H AD - Department of Laboratory Medicine, Kanazawa University, Japan. FAU - Sakai, Norihiko AU - Sakai N AD - Division of Nephrology, Kanazawa University, Japan; Division of Blood Purification, Kanazawa University, Japan. FAU - Kitajima, Shinji AU - Kitajima S AD - Division of Nephrology, Kanazawa University, Japan; Department of Disease Control and Homeostasis, Kanazawa University, Japan. FAU - Toyama, Tadashi AU - Toyama T AD - Division of Nephrology, Kanazawa University, Japan; Department of Disease Control and Homeostasis, Kanazawa University, Japan. FAU - Shinozaki, Yasuyuki AU - Shinozaki Y AD - Division of Nephrology, Kanazawa University, Japan; Department of Laboratory Medicine, Kanazawa University, Japan. FAU - Sagara, Akihiro AU - Sagara A AD - Division of Nephrology, Kanazawa University, Japan; Department of Disease Control and Homeostasis, Kanazawa University, Japan. FAU - Matsushima, Kouji AU - Matsushima K AD - Department of Molecular Preventive Medicine, University of Tokyo, Tokyo, Japan. FAU - Kaneko, Shuichi AU - Kaneko S AD - Department of Disease Control and Homeostasis, Kanazawa University, Japan. FAU - Wada, Takashi AU - Wada T AD - Division of Nephrology, Kanazawa University, Japan; Department of Laboratory Medicine, Kanazawa University, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131219 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Chemokines) RN - 0 (Inflammasomes) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Cytokine) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Cell Line MH - Chemokines/genetics/metabolism MH - Epithelial Cells/*metabolism/pathology MH - Gene Expression Regulation/*drug effects MH - Glucose/*pharmacology MH - Humans MH - Inflammasomes/metabolism MH - Inflammation/*genetics/pathology MH - Intracellular Space/drug effects/metabolism MH - Kidney Tubules/*pathology MH - Mesangial Cells/*metabolism/pathology MH - Oxidative Stress/drug effects/genetics MH - Phenotype MH - Phosphorylation/drug effects MH - RNA, Messenger/genetics/metabolism MH - Receptors, Cytokine/genetics/metabolism MH - Signal Transduction/drug effects/genetics MH - TOR Serine-Threonine Kinases/metabolism MH - Th1 Cells/drug effects/*metabolism OTO - NOTNLM OT - Diabetic nephropathy OT - Genome-wide analysis OT - Inflammation OT - Mesangial cells OT - Tubular epithelial cells EDAT- 2013/12/24 06:00 MHDA- 2014/03/22 06:00 CRDT- 2013/12/24 06:00 PHST- 2013/11/28 00:00 [received] PHST- 2013/12/14 00:00 [accepted] PHST- 2013/12/24 06:00 [entrez] PHST- 2013/12/24 06:00 [pubmed] PHST- 2014/03/22 06:00 [medline] AID - S0006-291X(13)02141-4 [pii] AID - 10.1016/j.bbrc.2013.12.072 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2014 Jan 17;443(3):969-74. doi: 10.1016/j.bbrc.2013.12.072. Epub 2013 Dec 19.